Akari Therapeutics Plc - ADR

NASDAQ:AKTX   3:59:51 PM EDT
1.69
-0.05 (-2.87%)
Earnings Announcements

Akari Therapeutics PLC Reports Q2 2021 Financial Results

Published: 09/22/2021 14:09 GMT
Akari Therapeutics Plc - ADR (AKTX) - Akari Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Clinical Progress.
Akari Therapeutics Plc Qtrly Loss per Ordinary Share (basic and Diluted) $0.00.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.